Do you want to gain insights into the CVC portfolios of 19 Biopharma Companies and Google? Then read below!
Over the past few years, corporate venture capital (CVC) companies backed by or…
How can we address challenges in rare disease drug development?
It is estimated that rare diseases affect more than 400 million people…
Updated Guidelines for Childhood Obesity - Are Drugs and Surgery Options Suitable for Kids?
On January 9th, 2023, the American Academy of Pediatrics (AAP) released new…
Thinking of expanding into pharmerging markets? Then read below!
As Benjamin Franklin said, "By failing to plan, you are preparing to fail".…
How Gene Therapy sponsors can overcome regulatory approval bottlenecks.
In a previous article, we discussed the findings of a Linkedin poll regarding…
How are digital health applications and AI transforming healthcare?
When thinking of health apps, the most common ones coming into our minds are…
Can Predictive Analytics redefine how we conduct Clinical Trials?
Clinical trials are essential for developing new treatments, discovering new…
Psychedelics as medicine in psychiatry: A “mind-altering” update.
In human history, there is a long tradition of psychedelic compounds' medicinal…
What happened to the NFT hype? Shall we expect the broad adoption of NFTs in healthcare?
Last year we published the NFTS AND HEALTHCARE, A MATCH MADE IN HEAVEN(?),…
Gene therapy treatments for Inherited Retinal Disorders (IRD) hold great promise.
Globally 4.5 million people are affected by IRDs — a group of diseases having a…
Is telehealth solving health disparities for vulnerable populations?
The pandemic has forced HCPs to rethink care delivery, dramatically expanding…
Behavioral Health trends and challenges – where are we and what is coming up?
Behavioral health is a term used to describe everyday habits that affect a…